Also, treatment of NADPH oxidase inhibitor apocynin (30 μg/kg, intravenous) maintained baroreflex sensitivity revealing that ROS generated via NADPH oxidase pathway plays a key role in the modification of baroreflex sensitivity in hypertension, whereas treatment of antioxidants (vitamin C) restored this change [102]. The gene discussed is FMO5; the disease is hypertensive disorder.